Abstract
Bone health is a concern after bone marrow transplant (BMT). BMT patients are at higher risk of bone mineral density (BMD) loss and fragility fractures. Incidence of BMD loss is 50-75% after allogeneic BMT, with early significant changes within 3-6 months after transplant. Prevalence of fragility fractures is 2-8%, eight times that of age matched population. The American Society for Transplantation and Cellular Therapy (ASTCT) recently published expert opinion guidelines. Our goal was to evaluate the allogenic BMT population at our academic medical center in light of these guidelines to improve management.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
